Oncimmune Set For Bigger US Push Of Early-Stage Lung Cancer Test
This article was originally published in Clinica
Executive Summary
Oncimmune Ltd is seeking new distribution partners in the US as it expands the commercialization of its blood-based immunoassay for early-stage lung cancer, the only one of its kind in the market.